HIF1A and myopia: This study aims to determine whether atropine inhibits myopia progression by improving choroidal microcirculation and scleral hypoxia, inhibiting the HIF-1α signaling pathway, and targeting MRs on scleral fibroblasts to inhibit ECM production and remodeling.